Descrizione
Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes.
Cite This Figure
 > Source: Sarah Schaffer et al. "A Scoping Review of Exosome Delivery Applications in Hair Loss.." *Cureus*, 2025. PMID: [40276450](https://pubmed.ncbi.nlm.nih.gov/40276450/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020662/bin/cureus-0017-00000081152-i02.jpg" alt="Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes." /> <figcaption>Figure 2. Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes.<br> Source: Sarah Schaffer et al. "A Scoping Review of Exosome Delivery Applications in Hair Loss.." <em>Cureus</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40276450/">40276450</a></figcaption> </figure>
Evidenze correlate
A
Spironolattone per Alopecia androgenetica
A
Grado A · 45 studi
Minoxidil per Alopecia areata
A
Grado A · 122 studi
Minoxidil per Telogen effluvium
A
Grado A · 66 studi
Microneedling per Alopecia areata
A
Grado A · 34 studi
Minoxidil per Alopecia androgenetica
A
Grado A · 299 studi
Acidi grassi Omega-3 per Alopecia androgenetica
A
Grado A · 71 studi
Microneedling per Alopecia androgenetica
B
Grado A · 62 studi
Ferro per Telogen effluvium
B
Grado B · 62 studi
Acidi grassi Omega-3 per Telogen effluvium
Grado B · 11 studi